drugset / Trial / NCT05239598

Povidone-Iodine Oral Rinse Study

NCT05239598

Phase 2 Completed 40 enrolled University of Pennsylvania Avrio Health · collab
RandomizedParallel-groupTriple-blindPrevention

Summary

This study is a two-arm, randomized, 2-phase study. Phase I will be double blinded clinical trial of the safety and efficacy of an antiseptic mouthwash solution on reducing SARS-CoV-2 load in COVID 19+ adult individuals. Phase II is designed as an open label trial, and all subjects will receive the active mouthwash.

Timeline

Start
2022-02-07
Primary completion
2022-07-07
Completion
2022-07-13

Drugs

EvaluationDrugModalityDoseRoute
Subject Povidone-Iodine Other / unclassified 10 ml Other

Indications